Key market segments to watch

The global microbubbles/ultrasound contrast agents market studied in this report is majorly segmented on the basis of therapeutic area (cardiovascular diseases, renal and associated diseases, and others), application (molecular imaging, gene therapy, drug delivery, and stem cells delivery), and geography.

On the basis of therapeutic area, cardiovascular diseases commanded the largest share in the global microbubbles/ultrasound contrast agents market in 2017, mainly due to rising adoption of ultrasound contrast agents in echocardiography procedures with increasing prevalence of chronic cardiovascular diseases, rising mortality associated to stroke and heart attack, and need for better diagnosis technology.

On the basis of applications, molecular imaging held the largest share in the microbubbles/ultrasound contrast agents market in 2017. This was mainly attributed to rising adoption of microbubbles in various ultrasound based molecular imaging procedures for the accurate diagnosis of various diseases. In addition, increasing need for monitoring of the biomarker status of vascular endothelium, visualizing tumor vasculature, imaging inflammation and ischemia-reperfusion injury zones, and need for targeted therapies further propels the adoption of microbubbles in molecular imaging applications.


Regional market growth trends

Geographically, this market is segmented into North America, Europe, Asia Pacific, and rest of the World. North America commanded the largest share in the global microbubbles/ultrasound contrast agents market in 2017, followed by Europe and Asia-Pacific. The major share of this region is mainly attributed to the rising aging population, increasing number of chronic diseases, well-established healthcare system with wide spread chain of suppliers & distributors, higher adoption of innovative technologies, rising technological advancements in healthcare, and higher healthcare spending in the region, especially in the U.S. However, Asia pacific region is slated to register the fastest growth during the forecast period, primarily due to rising healthcare spending, improving healthcare infrastructure, rising living standards with increasing income of middle class population, growing healthcare awareness, and growing aging population and subsequently prevalence of chronic diseases in the Asian countries.

Key players in the global market

The key players in the global microbubbles/ultrasound contrast agents market are Lantheus Holdings, Inc., Bracco, GE Healthcare, Daiichi Sankyo Company, Limited, and nanoPET Pharma GmbH. These vendors employed various strategies to expand their product and application offerings, global footprint, and augment their market shares.

Browse in-depth Report on
https://www.meticulousresearch.com/product/microbubbles-ultrasound-contrast-agents-market-2024/

Key questions answered in the report-

Which are the high growth market segments in terms of therapeutic area, applications, and regions?
What is the historical market for microbubbles/ultrasound contrast agents across the globe?
What are the market forecasts and estimates from the period 2018-2024?
What are the major drivers, restraints, opportunities, and trends in the global microbubbles/ultrasound contrast agents market?
Who are the major players in the global microbubbles/ultrasound contrast agents market and what share of the market do they hold?
Who are the major players in various regions and what share of the market do they hold?
What are the competitive landscapes and who are the market leaders by region in the global microbubbles/ultrasound contrast agents market?
What are the recent developments in the global microbubbles/ultrasound contrast agents market?
What are the different strategies adopted by the major players in the global microbubbles/ultrasound contrast agents market?
What are the geographical trends andhigh growth regions?
Who are the local emerging players in the global microbubbles/ultrasound contrast agents market and how do they compete with the global players?
About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicated market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Meticulous Research® produces global reports and custom studies for North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa regions. These reports are used by our clients for marketing and strategic planning in various sectors.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Connect with us on Twitter- https://twitter.com/MeticulousR123

Share on